Filter news by date News Tags - Any -Key releaseNews storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year202320222021202020192018201720162015201420132012201120102009200820072006 Apply 10 . 3 . 2023 News story “A product for any type of skin”: celebrating Cetaphil’s range and reliability 10 . 2 . 2023 News story Alastin Skincare: Galderma announces launch in the UK and direct distribution and expansion in Canada 10 . 2 . 2023 Press release Galderma announces progress with RelabotulinumtoxinA regulatory submissions 9 . 14 . 2023 Press release Galderma launches advanced new serum with ALASTIN Skincare® - C-RADICAL Defense Antioxidant Serum 9 . 14 . 2023 News story Galderma’s World Eczema Week: driving change for the community 9 . 12 . 2023 Press release Powered by Peptides: Galderma introduces Cetaphil Healthy Renew, a retinol alternative skincare range 7 . 29 . 2023 Press release Galderma reiterates its commitment to commercialize and continue developing the broadest Injectable Aesthetics portfolio on the market, following Ipsen's recent announcement 7 . 27 . 2023 Press release Galderma achieves record 2 B USD net sales for a six-month period in H1 2023, as it continues to demonstrate leading execution and innovation capabilities in dermatology 7 . 4 . 2023 Press release Galderma @ WCD 2023: late-breaking phase III results for nemolizumab monotherapy in prurigo nodularis show a significant proportion of itch-free patients by week 4 6 . 28 . 2023 Press release WCD 2023: Galderma to present extensive data demonstrating enduring commitment to delivering innovative solutions in dermatology 6 . 28 . 2023 News story WCD 2023: Galderma’s scientific presentations 6 . 26 . 2023 Press release Galderma raises approximately USD 1 billion for newly issued shares in a private placement round 6 . 5 . 2023 Press release Galderma receives FDA approval for its newest hyaluronic acid filler, Restylane® Eyelight™ Pagination Next page Next Page